Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making

被引:28
作者
Teerawattananon, Yot [1 ,2 ]
Painter, Chris [1 ]
Dabak, Saudamini [1 ]
Ottersen, Trygve [3 ]
Gopinathan, Unni [3 ]
Chola, Lumbwe [3 ]
Chalkidou, Kalipso [4 ,5 ]
Culyer, Anthony J. [6 ]
机构
[1] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program HITAP, Nonthaburi, Thailand
[2] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[3] Norwegian Inst Publ Hlth, Oslo, Norway
[4] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland
[5] Imperial Coll London, London, England
[6] Univ York, York, N Yorkshire, England
基金
比尔及梅琳达.盖茨基金会;
关键词
COST-EFFECTIVENESS ANALYSIS; ECONOMIC-EVALUATION;
D O I
10.1186/s12962-021-00308-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Despite the documented benefits of using health technology assessments (HTA) to inform resource allocation in health care systems, HTA remains underused, especially in low- and middle-income countries. A survey of global health practitioners was conducted to reveal the top reasons ("excuses") that they had heard from colleagues, policymakers or other stakeholders for not using HTA in their settings. Methods: There were 193 respondents to the survey. Most responses were from individuals in research organisations (37%), ministries of health (27%) and other government agencies (14%). Participants came from Southeast Asia (40%), the Western Pacific (30%), Africa (15%), Europe (7%), the Americas (7%) and the Eastern Mediterranean region (2%). Results: The top five reasons encountered by respondents related to lack of data, lack of technical skills for HTA, the technocratic nature of the work, the lack of explicit decision rules and the perception that HTA puts a "price on life". Conclusions: This study aimed to understand and address the top reasons for not using HTA. They fall into three categories: (1) misconceptions about HTA; (2) feasibility issues; and (3) values, attitudes and politics. Previous literature has shown that these reasons can be addressed when identified, and even imperfect HTA analyses can provide useful information to a decision-maker.
引用
收藏
页数:8
相关论文
共 31 条
[1]   The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries' Health Economics Practitioners: A Commentary [J].
Adeagbo, Chiaki Urai ;
Rattanavipapong, Waranya ;
Guinness, Lorna ;
Teerawattananon, Yot .
VALUE IN HEALTH, 2018, 21 (05) :569-572
[2]  
[Anonymous], 2015, RETURNS RES FUNDED N
[3]  
[Anonymous], 2015, 2015 Global Survey on Health Technology Assessment by National Authorities Internet
[4]   Distributional Cost-Effectiveness Analysis: A Tutorial [J].
Asaria, Miqdad ;
Griffin, Susan ;
Cookson, Richard .
MEDICAL DECISION MAKING, 2016, 36 (01) :8-19
[5]   Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review [J].
Avancena, Anton L., V ;
Prosser, Lisa A. .
VALUE IN HEALTH, 2021, 24 (01) :136-143
[6]  
Barlow E., 2021, RESEARCHGATE, DOI [10.13140/RG.2.2.23649.63841, DOI 10.13140/RG.2.2.23649.63841]
[7]   Illustrating Potential Efficiency Gains from Using Cost-Effectiveness Evidence to Reallocate Medicare Expenditures [J].
Chambers, James D. ;
Lord, Joanne ;
Cohen, Joshua T. ;
Neumann, Peter J. ;
Buxton, Martin J. .
VALUE IN HEALTH, 2013, 16 (04) :629-638
[8]  
Chanphothong V, 2019, GUEST BLOG REFL BUDD
[9]  
Chootipongchaivat S, 2016, Policy brief and working paper. Conducive factors to the development of health technology assessment in Asia
[10]  
Cookson R., 2020, Distributional cost-effectiveness analysis: quantifying health equity impacts and trade-offs, DOI [10.1093/med/9780198838197.001.0001, DOI 10.1093/MED/9780198838197.001.0001]